Join the Acute Lymphocytic Leukemia group to help and get support from people like you.
Acute Lymphocytic Leukemia News
Related terms: Acute childhood leukemia, Acute Lymphocytic Leukemia (ALL), Cancer, Acute Childhood Leukemia, Cancer, Acute Lymphocytic Leukemia, Leukemia, Acute Childhood, Leukemia, Acute Lymphocytic, ALL, ALL Leukemia
Disparities Identified in Leukemia Incidence, Mortality in Florida
TUESDAY, March 25, 2025 – There are racial and geographic disparities in the incidence of and mortality from adult leukemia in Florida, where the incidence of leukemia is the highest in the United...
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM
MONDAY, March 10, 2025 – For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for developing hematologic cancers...
American Society of Hematology, Dec. 7 to 10
The annual meeting of the American Society of Hematology was held from Dec. 7 to 10 in San Diego and attracted participants from around the world, including hematology specialists as well as clinical ...
Ophthalmologic Manifestations of Acute Leukemia Are Heterogeneous
WEDNESDAY, July 17, 2024 – Ophthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a study published online July 10 in the...
FDA Approves Asparlas (calaspargase pegol-mknl) for Acute Lymphoblastic Leukemia (ALL)
On December 20, 2018, the Food and Drug Administration approved calaspargase pegol-mknl (Asparlas, Servier Pharmaceuticals LLC), an asparagine specific enzyme, as a component of a multi-agent...
FDA Approves Erwinaze to Treat Acute Lymphoblastic Leukemia
November 18, 2011 – The U.S. Food and Drug Administration today approved Erwinaze (asparaginase Erwinia chrysanthemi) to treat patients with acute lymphoblastic leukemia (ALL), who have developed an...